A Randomized Study of Antineoplaston Therapy vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma
This study is not yet open for participant recruitment.
Verified December 2010 by Burzynski Research Institute
Sponsor:
Burzynski Research Institute
Information provided by:
Burzynski Research Institute
ClinicalTrials.gov Identifier:
NCT01260103
First received: December 13, 2010
Last updated: NA
Last verified: December 2010
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |